share_log

复旦张江(01349.HK)8月12日举行董事会会议审议及通过中期业绩

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) held a board of directors meeting on August 12 to review and approve its interim performance.

Gelonghui Finance ·  Jul 29 05:03

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that it will hold a board of directors meeting on August 12, 2024 (Monday) to consider and approve (including) the unaudited interim performance of the company and its subsidiaries for the six months ended June 30, 2024 and the declaration of interim dividends (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment